Pfizer (PFE) Tops Q1 EPS by 12c; Boosts FY16 Outlook

Pfizer (NYSE: PFE) reported Q1 EPS of $0.67, $0.12 better than the analyst estimate of $0.55. Revenue for the quarter came in at $13 billion versus the consensus estimate of $12 billion.

GUIDANCE:

Pfizer sees FY2016 EPS of $2.38 - $2.48, versus prior guidance of $2.20 - $2.30 and the consensus of $2.30. Pfizer sees FY2016 revenue of $51 - $53 billion, versus prior guidance of $49 - $51 billion and the consensus of $51.24 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings